Back to KROS

UBS Group AG → KROS

UBS Group AG KROS Position History

Keros Therapeutics, Inc. • Healthcare

Quarters held
10
Latest value
$1.4M
Q3 2026
Peak value
$2M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$1.6M
Q4 2025$2M
Q4 2025$6K
Q1 2026$3K
Q1 2026$1.5M
Q1 2026$88K
Q2 2026$1K
Q2 2026$1.5M
Q3 2026$3K
Q3 2026$1.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$1.4M120.5K——
Q3 2026$3K223——
Q2 2026$1.5M137.9K——
Q2 2026$1K115——
Q1 2026$88K8.0K——
Q1 2026$1.5M137.3K——
Q1 2026$3K285——
Q4 2025$6K271——
Q4 2025$2M96.8K——
Q3 2025$1.6M103.9K——

Other funds holding KROS

$288.7M
$240.4M
$182.8M
$175.4M
$171.8M
$163.6M
$161.9M
$144.3M

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B